Your browser doesn't support javascript.
loading
Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome.
Hamada, Marina; Hida, Tokimasa; Idogawa, Masashi; Tange, Shoichiro; Kamiya, Takafumi; Okura, Masae; Yamashita, Toshiharu; Tokino, Takashi; Uhara, Hisashi.
Affiliation
  • Hamada M; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Hida T; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Idogawa M; Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tange S; Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kamiya T; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Okura M; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Yamashita T; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Tokino T; Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Uhara H; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
J Dermatol ; 2024 Aug 19.
Article de En | MEDLINE | ID: mdl-39158191
ABSTRACT
Multiple hereditary infundibulocystic basal cell carcinoma syndrome (MHIBCC), an autosomal dominant disorder caused by variants in SUFU, is characterized by numerous infundibulocystic basal cell carcinomas (IBCCs). In this report, we present a possible case of mosaic MHIBCC. A 57-year-old woman underwent the removal of four papules on her face, which were diagnosed as IBCCs. Exome sequencing revealed a SUFU c.1022+1G>A mutation within the skin tumor. The same mutation was detected in her blood but at a lower allele frequency. TA cloning revealed that the allele frequency of the mutation in the blood was 0.07. Additionally, tumor assessment revealed loss of heterozygosity (LOH) in chromosome 10, including the SUFU locus. These results indicate the patient had mosaicism for the SUFU mutation in normal tissues, aligning with the mosaic MHIBCC diagnosis. This, combined with LOH, likely contributed to IBCC development. Mosaic MHIBCC may present with milder symptoms. However, it may still increase the risk of developing brain tumors and more aggressive basal cell carcinoma. The possibility of mosaicism should be investigated in mild MHIBCC cases, where standard genetic tests fail to detect SUFU germline variants.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Dermatol Année: 2024 Type de document: Article Pays d'affiliation: Japon

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: J Dermatol Année: 2024 Type de document: Article Pays d'affiliation: Japon